// App-Quantinova.ai

3066 : Feasibility to obtain a chemogram in circulating tumorigenic cells to guide further treatments in refractory solid tumors.

Researchers

Presenter

  • Antonio Cubillo

Principal Investigators

  • Antonio Calles

  • Pedro P. Lopez-Casas

  • Mark Ricigliano

  • Emiliano Calvo

  • Ignacio Duran

  • Fernando Lopez-Ros

  • Margarita Rodriguez

  • Manuel Hidalgo

Medical Centers

  • Laboratorio de Dianas Terapeuticas, CIOCC, Madrid, Spain

  • START Department, Centro Integral Oncologico Clara Campal, Madrid, Spain

  • CellPath Therapeuthics, Inc, Baltimore, MD

  • Clinical Research Programme, Spanish National Cancer Research Centre-CNIO, Madrid, Spain

Locations

  • United States

  • Spain

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • Circulating tumor cells

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved